NanoVation-GS is a med-tech startup aiming to help alleviate the suffering of hundreds of millions of patients and reduce the high financial burden due to frequent hospitalizations of chronic respiratory patients such as COPD and asthma.
SenseGuard™, developed by NanoVation-GS, is a reliable and patient-friendly solution for monitoring patients’ respiratory condition, measuring unique lung function biomarkers from effortless (tidal) breathing. Short measurements of 2-3 minutes once a day, enable disease management and early detection and treatment of exacerbations, before they reach acute stage that requires hospitalization.
Cumulative Funding Raised Over Time ($)
Employees Over Time
NanoVation-GS Climate Tech relevance
null
Latest News
No Data, yet.
Sorry, no content found under this section.
Jul 19, 2022
www.jpost.com
https://www.jpost.com/israel-news/article-712509
#Customers #Partners
Jul 5, 2021
www.calcalistech.com
NanoVation receives $5.9 million from European Innovation Council Fund for its respiratory monitoring device
#Investment
Jul 20, 2020
www.calcalistech.com
Israel medical startup NanoVation receives 2.5 million Euro grant from the European Union
#Investment
Nov 2, 2015
www.thetower.org
Israeli Startups Receive Grants to Develop Early Detection Devices for Pneumonia